Cargando…

Immunohistochemical Analysis of IDH2 R172 Hotspot Mutations in Breast Papillary Neoplasms: Applications in the Diagnosis of Tall Cell Carcinoma with Reverse Polarity

Tall cell carcinoma with reverse polarity is a rare subtype of breast carcinoma with solid and papillary growth and nuclear features reminiscent of those of the tall cell variant of papillary thyroid carcinoma. These tumors harbor recurrent IDH2 R172 hotspot mutations or TET2 mutations, co-occurring...

Descripción completa

Detalles Bibliográficos
Autores principales: Pareja, Fresia, da Silva, Edaise M., Frosina, Denise, Geyer, Felipe C., Lozada, John R., Basili, Thais, Da Cruz Paula, Arnaud, Zhong, Elaine, Derakhshan, Fatemeh, D’Alfonso, Timothy, Wen, Hannah Y., Giri, Dilip D., Hayes, Malcolm M., Krings, Gregor, Bhargava, Rohit, Palazzo, Juan P., Rakha, Emad A., Hoda, Syed A., Sanders, Melinda E., Collins, Laura C., Schnitt, Stuart J., Chen, Yunn-Yi, Weigelt, Britta, Jungbluth, Achim A., Reis-Filho, Jorge S., Brogi, Edi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286791/
https://www.ncbi.nlm.nih.gov/pubmed/31896809
http://dx.doi.org/10.1038/s41379-019-0442-2
_version_ 1783544931803987968
author Pareja, Fresia
da Silva, Edaise M.
Frosina, Denise
Geyer, Felipe C.
Lozada, John R.
Basili, Thais
Da Cruz Paula, Arnaud
Zhong, Elaine
Derakhshan, Fatemeh
D’Alfonso, Timothy
Wen, Hannah Y.
Giri, Dilip D.
Hayes, Malcolm M.
Krings, Gregor
Bhargava, Rohit
Palazzo, Juan P.
Rakha, Emad A.
Hoda, Syed A.
Sanders, Melinda E.
Collins, Laura C.
Schnitt, Stuart J.
Chen, Yunn-Yi
Weigelt, Britta
Jungbluth, Achim A.
Reis-Filho, Jorge S.
Brogi, Edi
author_facet Pareja, Fresia
da Silva, Edaise M.
Frosina, Denise
Geyer, Felipe C.
Lozada, John R.
Basili, Thais
Da Cruz Paula, Arnaud
Zhong, Elaine
Derakhshan, Fatemeh
D’Alfonso, Timothy
Wen, Hannah Y.
Giri, Dilip D.
Hayes, Malcolm M.
Krings, Gregor
Bhargava, Rohit
Palazzo, Juan P.
Rakha, Emad A.
Hoda, Syed A.
Sanders, Melinda E.
Collins, Laura C.
Schnitt, Stuart J.
Chen, Yunn-Yi
Weigelt, Britta
Jungbluth, Achim A.
Reis-Filho, Jorge S.
Brogi, Edi
author_sort Pareja, Fresia
collection PubMed
description Tall cell carcinoma with reverse polarity is a rare subtype of breast carcinoma with solid and papillary growth and nuclear features reminiscent of those of the tall cell variant of papillary thyroid carcinoma. These tumors harbor recurrent IDH2 R172 hotspot mutations or TET2 mutations, co-occurring with mutations in PI3K pathway genes. Diagnosis of tall cell carcinomas with reverse polarity is challenging in view of its rarity and the range of differential diagnosis. We sought to determine the sensitivity and specificity of IDH2 R172 immunohistochemistry for the detection of IDH2 R172 hotspot mutations in this entity. We evaluated 14 tall cell carcinomas with reverse polarity (ten excision and five core needle biopsy specimens), 13 intraductal papillomas, 16 solid papillary carcinomas and five encapsulated papillary carcinomas by Sanger sequencing of the IDH2 R172 hotspot locus and of exons 9 and 20 of PIK3CA, and by immunohistochemistry using monoclonal antibodies (11C8B1) to the IDH2 R172S mutation. The fourteen tall cell carcinomas with reverse polarity studied harbored IDH2 R172 hotspot mutations, which co-occurred with PIK3CA hotspot mutations in 50% of cases. None of the other papillary neoplasms analyzed displayed IDH2 R172 mutations, however PIK3CA hotspot mutations were detected in 54% of intraductal papillomas, 6% of solid papillary carcinomas and 20% of encapsulated papillary carcinomas tested. Immunohistochemical analysis with anti-IDH2 R172S antibodies (11C8B1) detected IDH2 R172 mutated protein in 93% (14/15) of tall cell carcinomas with reverse polarity samples including excision (n=9/10) and core needle biopsy specimens (n=5), whereas the remaining papillary neoplasms (n=34) were negative. Our findings demonstrate that immunohistochemical analysis of IDH2 R172 is highly sensitive and specific for the detection of IDH2 R172 hotspot mutations, and likely suitable as a diagnostic tool in the evaluation of excision and core needle biopsy material of tall cell carcinomas with reverse polarity.
format Online
Article
Text
id pubmed-7286791
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-72867912020-07-02 Immunohistochemical Analysis of IDH2 R172 Hotspot Mutations in Breast Papillary Neoplasms: Applications in the Diagnosis of Tall Cell Carcinoma with Reverse Polarity Pareja, Fresia da Silva, Edaise M. Frosina, Denise Geyer, Felipe C. Lozada, John R. Basili, Thais Da Cruz Paula, Arnaud Zhong, Elaine Derakhshan, Fatemeh D’Alfonso, Timothy Wen, Hannah Y. Giri, Dilip D. Hayes, Malcolm M. Krings, Gregor Bhargava, Rohit Palazzo, Juan P. Rakha, Emad A. Hoda, Syed A. Sanders, Melinda E. Collins, Laura C. Schnitt, Stuart J. Chen, Yunn-Yi Weigelt, Britta Jungbluth, Achim A. Reis-Filho, Jorge S. Brogi, Edi Mod Pathol Article Tall cell carcinoma with reverse polarity is a rare subtype of breast carcinoma with solid and papillary growth and nuclear features reminiscent of those of the tall cell variant of papillary thyroid carcinoma. These tumors harbor recurrent IDH2 R172 hotspot mutations or TET2 mutations, co-occurring with mutations in PI3K pathway genes. Diagnosis of tall cell carcinomas with reverse polarity is challenging in view of its rarity and the range of differential diagnosis. We sought to determine the sensitivity and specificity of IDH2 R172 immunohistochemistry for the detection of IDH2 R172 hotspot mutations in this entity. We evaluated 14 tall cell carcinomas with reverse polarity (ten excision and five core needle biopsy specimens), 13 intraductal papillomas, 16 solid papillary carcinomas and five encapsulated papillary carcinomas by Sanger sequencing of the IDH2 R172 hotspot locus and of exons 9 and 20 of PIK3CA, and by immunohistochemistry using monoclonal antibodies (11C8B1) to the IDH2 R172S mutation. The fourteen tall cell carcinomas with reverse polarity studied harbored IDH2 R172 hotspot mutations, which co-occurred with PIK3CA hotspot mutations in 50% of cases. None of the other papillary neoplasms analyzed displayed IDH2 R172 mutations, however PIK3CA hotspot mutations were detected in 54% of intraductal papillomas, 6% of solid papillary carcinomas and 20% of encapsulated papillary carcinomas tested. Immunohistochemical analysis with anti-IDH2 R172S antibodies (11C8B1) detected IDH2 R172 mutated protein in 93% (14/15) of tall cell carcinomas with reverse polarity samples including excision (n=9/10) and core needle biopsy specimens (n=5), whereas the remaining papillary neoplasms (n=34) were negative. Our findings demonstrate that immunohistochemical analysis of IDH2 R172 is highly sensitive and specific for the detection of IDH2 R172 hotspot mutations, and likely suitable as a diagnostic tool in the evaluation of excision and core needle biopsy material of tall cell carcinomas with reverse polarity. 2020-01-02 2020-06 /pmc/articles/PMC7286791/ /pubmed/31896809 http://dx.doi.org/10.1038/s41379-019-0442-2 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Pareja, Fresia
da Silva, Edaise M.
Frosina, Denise
Geyer, Felipe C.
Lozada, John R.
Basili, Thais
Da Cruz Paula, Arnaud
Zhong, Elaine
Derakhshan, Fatemeh
D’Alfonso, Timothy
Wen, Hannah Y.
Giri, Dilip D.
Hayes, Malcolm M.
Krings, Gregor
Bhargava, Rohit
Palazzo, Juan P.
Rakha, Emad A.
Hoda, Syed A.
Sanders, Melinda E.
Collins, Laura C.
Schnitt, Stuart J.
Chen, Yunn-Yi
Weigelt, Britta
Jungbluth, Achim A.
Reis-Filho, Jorge S.
Brogi, Edi
Immunohistochemical Analysis of IDH2 R172 Hotspot Mutations in Breast Papillary Neoplasms: Applications in the Diagnosis of Tall Cell Carcinoma with Reverse Polarity
title Immunohistochemical Analysis of IDH2 R172 Hotspot Mutations in Breast Papillary Neoplasms: Applications in the Diagnosis of Tall Cell Carcinoma with Reverse Polarity
title_full Immunohistochemical Analysis of IDH2 R172 Hotspot Mutations in Breast Papillary Neoplasms: Applications in the Diagnosis of Tall Cell Carcinoma with Reverse Polarity
title_fullStr Immunohistochemical Analysis of IDH2 R172 Hotspot Mutations in Breast Papillary Neoplasms: Applications in the Diagnosis of Tall Cell Carcinoma with Reverse Polarity
title_full_unstemmed Immunohistochemical Analysis of IDH2 R172 Hotspot Mutations in Breast Papillary Neoplasms: Applications in the Diagnosis of Tall Cell Carcinoma with Reverse Polarity
title_short Immunohistochemical Analysis of IDH2 R172 Hotspot Mutations in Breast Papillary Neoplasms: Applications in the Diagnosis of Tall Cell Carcinoma with Reverse Polarity
title_sort immunohistochemical analysis of idh2 r172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286791/
https://www.ncbi.nlm.nih.gov/pubmed/31896809
http://dx.doi.org/10.1038/s41379-019-0442-2
work_keys_str_mv AT parejafresia immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT dasilvaedaisem immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT frosinadenise immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT geyerfelipec immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT lozadajohnr immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT basilithais immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT dacruzpaulaarnaud immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT zhongelaine immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT derakhshanfatemeh immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT dalfonsotimothy immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT wenhannahy immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT giridilipd immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT hayesmalcolmm immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT kringsgregor immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT bhargavarohit immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT palazzojuanp immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT rakhaemada immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT hodasyeda immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT sandersmelindae immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT collinslaurac immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT schnittstuartj immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT chenyunnyi immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT weigeltbritta immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT jungbluthachima immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT reisfilhojorges immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity
AT brogiedi immunohistochemicalanalysisofidh2r172hotspotmutationsinbreastpapillaryneoplasmsapplicationsinthediagnosisoftallcellcarcinomawithreversepolarity